India may issue an alert on cough syrup exported by Marion Biotech, whose products have been linked to deaths in Uzbekistan, after tests showed many of the company’s drug samples contained toxins, a drug inspector said on Saturday.
https://www.pharmalive.com/wp-content/uploads/2023/03/ReutersMarionBiotech3-4-2023.jpg8001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-03-04 06:19:152023-03-06 11:19:24Exclusive: India may issue alert on Marion cough syrup exports after toxins found